CYMABAY THERAPEUTICS INC shareholders Q3 2023

CYMABAY THERAPEUTICS INC's ticker is CBAY and the CUSIP is 23257D103. A total of 194 filers reported holding CYMABAY THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 1.14 and the average weighting 0.4%.

CYMABAY THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
UBS ASSET MANAGEMENT AMERICAS LLC 76,126$1,135,0390.00%
GTS SECURITIES LLC 36,600$545,7060.00%
Ensign Peak Advisors, Inc 41,250$615,0380.00%
Activest Wealth Management 69$1,0290.00%
MORGAN STANLEY 507,471$7,566,3930.00%
PRIVATE TRUST CO NA 312$4,6520.00%
SIMPLEX TRADING, LLC 55,629$8290.00%
Tower Research Capital LLC (TRC) 1,881$28,0460.00%
Belvedere Trading LLC 27,800$414,4980.00%
Parallax Volatility Advisers, L.P. 15,700$234,0870.00%
EverSource Wealth Advisors, LLC 509$7,5890.00%
BARCLAYS PLC 83,800$1,2500.00%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 156,053$2,326,7500.00%
BANK OF AMERICA CORP /DE/ 58,628$874,1430.00%
Parallel Advisors, LLC 94$1,4020.00%
MILLENNIUM MANAGEMENT LLC 45,900$684,3690.00%
OSAIC HOLDINGS, INC. 4,161$62,0290.00%
NISA INVESTMENT ADVISORS, LLC 2,091$31,1770.00%
IFP Advisors, Inc 650$9,6920.00%
CITIGROUP INC 18,414$274,5520.00%
External links

This page lists CYMABAY THERAPEUTICS INC's shareholders in Q3 2023. To view CYMABAY THERAPEUTICS INC's shareholder history, click here.